Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Polarized localization of phosphatidylserine in the endothelium regulates Kir2.1
Claire A. Ruddiman, Richard Peckham, Melissa A. Luse, Yen-Lin Chen, Maniselvan Kuppusamy, Bruce A. Corliss, P. Jordan Hall, Chien-Jung Lin, Shayn M. Peirce, Swapnil K. Sonkusare, Robert P. Mecham, Jessica E. Wagenseil, Brant E. Isakson
Claire A. Ruddiman, Richard Peckham, Melissa A. Luse, Yen-Lin Chen, Maniselvan Kuppusamy, Bruce A. Corliss, P. Jordan Hall, Chien-Jung Lin, Shayn M. Peirce, Swapnil K. Sonkusare, Robert P. Mecham, Jessica E. Wagenseil, Brant E. Isakson
View: Text | PDF
Research Article Vascular biology

Polarized localization of phosphatidylserine in the endothelium regulates Kir2.1

  • Text
  • PDF
Abstract

Lipid regulation of ion channels is largely explored using in silico modeling with minimal experimentation in intact tissue; thus, the functional consequences of these predicted lipid-channel interactions within native cellular environments remain elusive. The goal of this study is to investigate how lipid regulation of endothelial Kir2.1 — an inwardly rectifying potassium channel that regulates membrane hyperpolarization — contributes to vasodilation in resistance arteries. First, we show that phosphatidylserine (PS) localizes to a specific subpopulation of myoendothelial junctions (MEJs), crucial signaling microdomains that regulate vasodilation in resistance arteries, and in silico data have implied that PS may compete with phosphatidylinositol 4,5-bisphosphate (PIP2) binding on Kir2.1. We found that Kir2.1-MEJs also contained PS, possibly indicating an interaction where PS regulates Kir2.1. Electrophysiology experiments on HEK cells demonstrate that PS blocks PIP2 activation of Kir2.1 and that addition of exogenous PS blocks PIP2-mediated Kir2.1 vasodilation in resistance arteries. Using a mouse model lacking canonical MEJs in resistance arteries (Elnfl/fl/Cdh5-Cre), PS localization in endothelium was disrupted and PIP2 activation of Kir2.1 was significantly increased. Taken together, our data suggest that PS enrichment to MEJs inhibits PIP2-mediated activation of Kir2.1 to tightly regulate changes in arterial diameter, and they demonstrate that the intracellular lipid localization within the endothelium is an important determinant of vascular function.

Authors

Claire A. Ruddiman, Richard Peckham, Melissa A. Luse, Yen-Lin Chen, Maniselvan Kuppusamy, Bruce A. Corliss, P. Jordan Hall, Chien-Jung Lin, Shayn M. Peirce, Swapnil K. Sonkusare, Robert P. Mecham, Jessica E. Wagenseil, Brant E. Isakson

×

Figure 3

PS colocalizes with Kir2.1 in a subpopulation of MEJs.

Options: View larger image (or click on image) Download as PowerPoint
PS colocalizes with Kir2.1 in a subpopulation of MEJs.
(A–C) Representat...
(A–C) Representative stitched confocal image of a third-order mesenteric artery prepared en face and stained for PS (magenta) (A), PS and IEL (gray) detected via Alexa Fluor 488-linked hydrazide (B), and merge with nuclei (blue) detected via DAPI and interendothelial junctions (green) detected via claudin-5 (C). Arrowheads show PS localized to MEJ. Scale bar: 30 μm in both directions. (D) Percentage of MEJs in endothelium containing PS. (E) Number of MEJs containing PS per EC, where EC borders were defined via claudin-5 staining. n = 4 mice, n = 4 arteries, n = 12 ROIs, and n = 205 ECs. (F) Spatial analysis of PS-MEJ compared with positive control (PC), random (RAND), and negative control (NC) simulations. Brown-Forsythe and Welch ANOVA with Holm-Sidak multiple comparisons, where #P < 0.0001 significant difference from real-world MEJ distribution, *P < 0.0001 significant difference from random simulation distribution, $P < 0.0001 significant difference from PC simulation distribution, and &P < 0.0001 significant difference from NC simulation distribution. n = 3 mice, n = 4 arteries, n = 4 ROIs, n = 66 PS-MEJs, and area = 4.49 × 104 μm2. (G) En face images of third-order mesenteric arteries with IEL (gray), PS (magenta), Kir2.1 (cyan), and Cx40 (yellow). Scale bar: 10 μm. Arrowheads indicate colocalization of PS and Kir2.1 to MEJ or only Cx40 to MEJ, and arrow indicates localization of only PS to MEJ. (H and I) In-house Matlab analysis to detect incidence of PS and Kir2.1 or PS and Cx40 colocalization to MEJ in en face images. n = 4 mice and n = 4 arteries per group.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts